Trident Pharmaceuticals Overview
- Year Founded
-
2006

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Trident Pharmaceuticals General Information
Description
Developer of novel immunomodulatory drug products. The company develops therapies for autoimmune diseases and allergic diseases.
Contact Information
Website
www.tridentpharma.comCorporate Office
- 184 High Street
- Boston, MA 02110
- United States
Corporate Office
- 184 High Street
- Boston, MA 02110
- United States
Trident Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 01-Nov-2015 | Completed | Out of Business | |||
3. Later Stage VC | 21-May-2014 | Completed | Generating Revenue | |||
2. Later Stage VC | 01-Sep-2012 | Completed | Generating Revenue | |||
1. Early Stage VC | 01-Mar-2006 | Completed | Startup |
Trident Pharmaceuticals Comparisons
Industry
Financing
Details
Trident Pharmaceuticals Competitors (40)
One of Trident Pharmaceuticals’s 40 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
Altimmune | Corporate Backed or Acquired | Gaithersburg, MD | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Anokion | Venture Capital-Backed | Ecublens, Switzerland | ||||
Hansa Biopharma | Corporation | Lund, Sweden |
Trident Pharmaceuticals Patents
Trident Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2003261492-A1 | Vaccine | Active | 08-May-1998 | ||
AU-2003261492-B2 | Vaccine | Inactive | 08-May-1998 | ||
US-7914791-B1 | Vaccine | Inactive | 08-May-1998 | ||
EP-1075274-A2 | Immunomodulators for vaccines | Inactive | 08-May-1998 | ||
CA-2331832-A1 | E.coli heat-labile enterotoxin subunit b (etxb) as an immunomodulator | Inactive | 08-May-1998 | A61K39/245 |
Trident Pharmaceuticals FAQs
-
When was Trident Pharmaceuticals founded?
Trident Pharmaceuticals was founded in 2006.
-
Where is Trident Pharmaceuticals headquartered?
Trident Pharmaceuticals is headquartered in Boston, MA.
-
What industry is Trident Pharmaceuticals in?
Trident Pharmaceuticals’s primary industry is Biotechnology.
-
Is Trident Pharmaceuticals a private or public company?
Trident Pharmaceuticals is a Private company.
-
What is Trident Pharmaceuticals’s current revenue?
The current revenue for Trident Pharmaceuticals is
. -
How much funding has Trident Pharmaceuticals raised over time?
Trident Pharmaceuticals has raised $275K.
-
Who are Trident Pharmaceuticals’s competitors?
Inovio Pharmaceuticals, Altimmune, NexImmune, Anokion, and Hansa Biopharma are some of the 40 competitors of Trident Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »